Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides

Tsutomu Ishihara, Maoko Goto, Kanae Kodera, Hideko Kanazawa, Yasuko Murakami, Yutaka Mizushima, Megumu Higaki

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

To achieve the effective intracellular delivery of siRNA and silence specific genes, various types of conjugates between cell-penetrating peptides (CPPs; Transportan, Penetratin, Tat) and cationic peptides were developed. Uptake, intracellular localization, cytotoxicity, and biological activity of siRNA were significantly dependent on the kind of CPP used and the length of the cationic peptides in the conjugate. Transportan-based conjugates yielded both high internalization of siRNA and strong gene silencing activity, while Penetratin- and Tat-based conjugates did not. These different properties of CPPs emphasize the importance of careful peptide selection and design when attempting the application of CPP technology.

Original languageEnglish
Pages (from-to)153-159
Number of pages7
JournalDrug Delivery
Volume16
Issue number3
DOIs
Publication statusPublished - 2009

Fingerprint

Cell-Penetrating Peptides
Oligopeptides
Small Interfering RNA
Peptides
Gene Silencing
Technology
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Genes
transportan
penetratin

Keywords

  • Cationic peptide
  • Cell-penetrating peptide
  • Endocytosis
  • Intracellular delivery
  • SiRNA

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides. / Ishihara, Tsutomu; Goto, Maoko; Kodera, Kanae; Kanazawa, Hideko; Murakami, Yasuko; Mizushima, Yutaka; Higaki, Megumu.

In: Drug Delivery, Vol. 16, No. 3, 2009, p. 153-159.

Research output: Contribution to journalArticle

Ishihara, T, Goto, M, Kodera, K, Kanazawa, H, Murakami, Y, Mizushima, Y & Higaki, M 2009, 'Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides', Drug Delivery, vol. 16, no. 3, pp. 153-159. https://doi.org/10.1080/10717540902722774
Ishihara, Tsutomu ; Goto, Maoko ; Kodera, Kanae ; Kanazawa, Hideko ; Murakami, Yasuko ; Mizushima, Yutaka ; Higaki, Megumu. / Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides. In: Drug Delivery. 2009 ; Vol. 16, No. 3. pp. 153-159.
@article{1adbf50c586748c2a2e9589410d32dbb,
title = "Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides",
abstract = "To achieve the effective intracellular delivery of siRNA and silence specific genes, various types of conjugates between cell-penetrating peptides (CPPs; Transportan, Penetratin, Tat) and cationic peptides were developed. Uptake, intracellular localization, cytotoxicity, and biological activity of siRNA were significantly dependent on the kind of CPP used and the length of the cationic peptides in the conjugate. Transportan-based conjugates yielded both high internalization of siRNA and strong gene silencing activity, while Penetratin- and Tat-based conjugates did not. These different properties of CPPs emphasize the importance of careful peptide selection and design when attempting the application of CPP technology.",
keywords = "Cationic peptide, Cell-penetrating peptide, Endocytosis, Intracellular delivery, SiRNA",
author = "Tsutomu Ishihara and Maoko Goto and Kanae Kodera and Hideko Kanazawa and Yasuko Murakami and Yutaka Mizushima and Megumu Higaki",
year = "2009",
doi = "10.1080/10717540902722774",
language = "English",
volume = "16",
pages = "153--159",
journal = "Drug Delivery",
issn = "1071-7544",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides

AU - Ishihara, Tsutomu

AU - Goto, Maoko

AU - Kodera, Kanae

AU - Kanazawa, Hideko

AU - Murakami, Yasuko

AU - Mizushima, Yutaka

AU - Higaki, Megumu

PY - 2009

Y1 - 2009

N2 - To achieve the effective intracellular delivery of siRNA and silence specific genes, various types of conjugates between cell-penetrating peptides (CPPs; Transportan, Penetratin, Tat) and cationic peptides were developed. Uptake, intracellular localization, cytotoxicity, and biological activity of siRNA were significantly dependent on the kind of CPP used and the length of the cationic peptides in the conjugate. Transportan-based conjugates yielded both high internalization of siRNA and strong gene silencing activity, while Penetratin- and Tat-based conjugates did not. These different properties of CPPs emphasize the importance of careful peptide selection and design when attempting the application of CPP technology.

AB - To achieve the effective intracellular delivery of siRNA and silence specific genes, various types of conjugates between cell-penetrating peptides (CPPs; Transportan, Penetratin, Tat) and cationic peptides were developed. Uptake, intracellular localization, cytotoxicity, and biological activity of siRNA were significantly dependent on the kind of CPP used and the length of the cationic peptides in the conjugate. Transportan-based conjugates yielded both high internalization of siRNA and strong gene silencing activity, while Penetratin- and Tat-based conjugates did not. These different properties of CPPs emphasize the importance of careful peptide selection and design when attempting the application of CPP technology.

KW - Cationic peptide

KW - Cell-penetrating peptide

KW - Endocytosis

KW - Intracellular delivery

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=70349338663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349338663&partnerID=8YFLogxK

U2 - 10.1080/10717540902722774

DO - 10.1080/10717540902722774

M3 - Article

C2 - 19514975

AN - SCOPUS:70349338663

VL - 16

SP - 153

EP - 159

JO - Drug Delivery

JF - Drug Delivery

SN - 1071-7544

IS - 3

ER -